BFA
CBIO

BlackRock Fund Advisors’s Crescent Biopharma CBIO Stock Holding History

BlackRock Fund Advisors’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2.43M Buy
3,978
+761
+24% +$475K ﹤0.01% 3127
2016
Q3 		$2.3M Buy
3,217
+518
+19% +$396K ﹤0.01% 3129
2016
Q2 		$1.96M Buy
2,699
+2,454
+1,002% +$1.69M ﹤0.01% 3195
2016
Q1 		$146K Sell
245
-19
-7% -$9.74K ﹤0.01% 3566
2015
Q4 		$151K Buy
264
+10
+4% +$6.63K ﹤0.01% 3627
2015
Q3 		$142K Sell
254
-7
-3% -$5.05K ﹤0.01% 3602
2015
Q2 		$207K Buy
261
+32
+14% +$26.5K ﹤0.01% 3521
2015
Q1 		$191K Sell
229
-16
-7% -$12.4K ﹤0.01% 3501
2014
Q4 		$176K Buy
245
+18
+8% +$14.1K ﹤0.01% 3517
2014
Q3 		$158K Sell
227
-17
-7% -$13.8K ﹤0.01% 3548
2014
Q2 		$206K Sell
244
-1,970
-89% -$1.96M ﹤0.01% 3481
2014
Q1 		$3.62M Buy
+2,214
New +$2.68M ﹤0.01% 2985

Other funds holding CBIO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $581M AUM 108.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return